Top of this page
Skip navigation, go straight to the content Home

UCB Statement on COVID-19 Outbreak

Patients are at the heart of everything we do, and UCB is committed to helping those impacted by the novel coronavirus, COVID-19. This includes helping patients maintain access to and answering any questions about UCB medicines, as well as putting patient and community care first in all our actions during these uncertain times.


UCB Statement on Racism and Racial Injustice

Over the last several weeks, UCB has shared deep concern and sadness about the state of racial injustice and heinous acts of violence against Black Americans happening in our country. We remain committed to living our Patient Value Principles to respect all people and to embrace diversity of thought, experience, and background. At UCB, we do not tolerate racism and racial injustice in any form.


U.S. Innovation

image description

U.S. Impact

image description

Information for Patients

image description

UCB is a global biopharmaceutical company focused on creating value for people living with severe diseases.


Latest News